Literature DB >> 22664917

MicroRNAs, wild-type and mutant p53: more questions than answers.

Matthew Jones1, Ashish Lal.   

Abstract

The tumor suppressor p53 is a sequence-specific transcription factor that activates the expression of genes involved in apoptosis, cell cycle arrest and senescence. p53 can also inhibit gene expression and this effect is partly mediated by inducing several microRNAs (miRNAs). MiRNAs have emerged as a new class of regulators of the expression and function of eukaryotic genomes. Tumor suppressive or oncogenic functions have been attributed to some miRNAs. Recent studies have shown that p53 can alter the transcription of several miRNAs, and in some cases, it can also influence miRNA maturation. Conversely, miRNAs can also modulate the abundance and activity of p53 by direct or indirect mechanisms. Moreover, mutant p53 can actively repress the expression of some miRNAs that are activated by wild-type p53. In this review, we discuss recent evidences of this crosstalk between miRNAs and the p53 network and also highlight its implications in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664917      PMCID: PMC3495745          DOI: 10.4161/rna.20146

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  156 in total

1.  Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Authors:  D Matas; A Sigal; P Stambolsky; M Milyavsky; L Weisz; D Schwartz; N Goldfinger; V Rotter
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 3.  The p53 tumor suppressor participates in multiple cell cycle checkpoints.

Authors:  Luciana E Giono; James J Manfredi
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

4.  The code within the code: microRNAs target coding regions.

Authors:  Joshua J Forman; Hilary A Coller
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

Review 5.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

7.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 8.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

9.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

10.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

View more
  24 in total

1.  Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.

Authors:  Nikhil S Chari; Cristina Ivan; Xiandong Le; Jinzhong Li; Ainiwaer Mijiti; Ameeta A Patel; Abdullah A Osman; Christine B Peterson; Michelle D Williams; Curtis R Pickering; Carlos Caulin; Jeffrey N Myers; George A Calin; Stephen Y Lai
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

2.  Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death.

Authors:  M F Jones; X Ling Li; M Subramanian; Svetlana A Shabalina; T Hara; Y Zhu; J Huang; Y Yang; L M Wakefield; K V Prasanth; A Lal
Journal:  Cell Death Differ       Date:  2015-02-20       Impact factor: 15.828

3.  The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.

Authors:  Matthew F Jones; Toshifumi Hara; Princy Francis; Xiao Ling Li; Sven Bilke; Yuelin Zhu; Marbin Pineda; Murugan Subramanian; Walter F Bodmer; Ashish Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

Review 4.  The Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses.

Authors:  Camilla Capaccia; Silvana Diverio; Danilo Zampini; Gabriella Guelfi
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

Review 5.  Roles of microRNA on cancer cell metabolism.

Authors:  Bing Chen; Hongbin Li; Xiao Zeng; Pengbo Yang; Xinyu Liu; Xia Zhao; Shufang Liang
Journal:  J Transl Med       Date:  2012-11-20       Impact factor: 5.531

Review 6.  Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

Authors:  Liz J Hernández Borrero; Wafik S El-Deiry
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-04-29       Impact factor: 11.414

7.  Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes.

Authors:  Brigitta László; László Antal; Eszter Gyöngyösi; Anita Szalmás; Szilárd Póliska; György Veress; József Kónya
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

Review 8.  Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer.

Authors:  Arkadiusz Gajek; Patrycja Gralewska; Agnieszka Marczak; Aneta Rogalska
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

Review 9.  MicroRNAs and Potential Targets in Osteosarcoma: Review.

Authors:  Valerie B Sampson; Soonmoon Yoo; Asmita Kumar; Nancy S Vetter; E Anders Kolb
Journal:  Front Pediatr       Date:  2015-08-24       Impact factor: 3.418

10.  Long Non-Coding RNAs Embedded in the Rb and p53 Pathways.

Authors:  Murugan Subramanian; Matthew F Jones; Ashish Lal
Journal:  Cancers (Basel)       Date:  2013-12-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.